back
SEDI Insider filing browser
| Date | Issuer | Insider | Transaction | Amount | New Balance ⓘ
The balance of securities held by registered holder at the time of the transaction. Insiders may direct multiple registered holders and hold multiple security types.
|
|
|---|---|---|---|---|---|---|
| Filed 2025-11-20 17:38 Tx date 2025-11-18 |
$BIOV
BioVaxys Technology Corp. |
Passin, James
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Warrants
16 - Acquisition or disposition under a prospectus exemption
|
+1,484,588 vol |
3,209,588 | |
| Filed 2025-11-20 17:30 Tx date 2025-11-18 |
$BIOV
BioVaxys Technology Corp. |
Passin, James
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
16 - Acquisition or disposition under a prospectus exemption
|
$252,379
+1,484,588 vol $0.17 each |
3,560,789 | |
| Filed 2025-11-03 12:36 Tx date 2025-10-30 |
$BIOV
BioVaxys Technology Corp. |
Passin, James
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
36 - Conversion or exchange
|
$25,239
+148,468 vol $0.17 each |
2,076,201 | |
| Filed 2025-11-03 12:34 Tx date 2025-10-30 |
$BIOV
BioVaxys Technology Corp. |
Passin, James
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Convertible Debentures
36 - Conversion or exchange
|
$
-$25,000 vol $0.17 each |
$0 | |
| Filed 2025-10-24 20:25 Tx date 2025-10-20 |
$BIOV
BioVaxys Technology Corp. |
Tartaglia, James
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+50,000 vol |
50,000 | |
| Filed 2025-10-24 20:24 Tx date 2025-10-08 |
$BIOV
BioVaxys Technology Corp. |
Tartaglia, James
4 - Director of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2025-10-24 19:43 Tx date 2025-10-20 |
$BIOV
BioVaxys Technology Corp. |
Kovan, Kenneth
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+125,000 vol |
475,000 | |
| Filed 2025-10-24 19:37 Tx date 2025-10-20 |
$BIOV
BioVaxys Technology Corp. |
Passin, James
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+125,000 vol |
475,000 | |
| Filed 2025-10-24 16:23 Tx date 2025-10-20 |
$BIOV
BioVaxys Technology Corp. |
Loverock, Craig William
4 - Director of Issuer
Holder: Loverock Consulting Corp (Indirect Ownership)
|
Options
50 - Grant of options
|
$6,250
+25,000 vol $0.25 each |
100,000 | |
| Filed 2025-10-24 16:20 Tx date 2022-09-07 |
$BIOV
BioVaxys Technology Corp. |
Loverock, Craig William
4 - Director of Issuer
Holder: Loverock Consulting Corp (Indirect Ownership)
|
Options
00 - Opening Balance-Initial SEDI Report
|
75,000 | ||
| Filed 2025-10-24 16:18 Tx date 2022-09-07 |
$BIOV
BioVaxys Technology Corp. |
Loverock, Craig William
4 - Director of Issuer
Holder: Loverock Consulting Corp (Indirect Ownership)
|
Options
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2025-09-23 15:09 Tx date 2025-09-15 |
$BIOV
BioVaxys Technology Corp. |
Kovan, Kenneth
5 - Senior Officer of Issuer
Direct Ownership
|
Convertible Debentures
16 - Acquisition or disposition under a prospectus exemption
|
+$25,000 vol |
$25,000 | |
| Filed 2025-09-23 14:59 Tx date 2025-09-15 |
$BIOV
BioVaxys Technology Corp. |
Kovan, Kenneth
5 - Senior Officer of Issuer
Direct Ownership
|
Warrants
16 - Acquisition or disposition under a prospectus exemption
|
+100,000 vol |
100,000 | |
| Filed 2025-09-23 14:51 Tx date 2020-09-30 |
$BIOV
BioVaxys Technology Corp. |
Kovan, Kenneth
5 - Senior Officer of Issuer
Direct Ownership
|
Convertible Debentures
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2025-09-23 14:49 Tx date 2024-01-14 |
$BIOV
BioVaxys Technology Corp. |
Kovan, Kenneth
5 - Senior Officer of Issuer
Direct Ownership
|
Warrants
55 - Expiration of warrants
|
-28,409 vol |
0 | |
| Filed 2025-09-23 14:46 Tx date 2025-09-11 |
$BIOV
BioVaxys Technology Corp. |
Kovan, Kenneth
5 - Senior Officer of Issuer
Direct Ownership
|
Options
37 - Stock split or consolidation
|
-3,150,000 vol |
350,000 | |
| Filed 2025-09-23 14:44 Tx date 2025-09-11 |
$BIOV
BioVaxys Technology Corp. |
Kovan, Kenneth
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
37 - Stock split or consolidation
|
-8,417,576 vol |
935,286 | |
| Filed 2025-09-23 11:34 Tx date 2020-09-30 |
$BIOV
BioVaxys Technology Corp. |
Kovan, Kenneth
5 - Senior Officer of Issuer
Direct Ownership
|
Convertible Debentures
00 - Opening Balance-Initial SEDI Report
|
$25,000 | ||
| Filed 2025-09-23 11:34 Tx date 2020-09-30 |
$BIOV
BioVaxys Technology Corp. |
Kovan, Kenneth
5 - Senior Officer of Issuer
Direct Ownership
|
Convertible Debentures
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2025-09-23 11:26 Tx date 2025-09-15 |
$BIOV
BioVaxys Technology Corp. |
Kovan, Kenneth
5 - Senior Officer of Issuer
Direct Ownership
|
Warrants
15 - Acquisition or disposition under a prospectus
|
$25,000
+100,000 vol $0.25 each |